# TVGN (Tevogen Inc.) - SEC EDGAR Financial Statements

> Tevogen Inc. reported $3.51M in total assets and a net loss of $22.89M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/TVGN
- Markdown: https://convexityos.com/fundamentals/TVGN.md
- SEC CIK: 0001860871
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:03 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001860871&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$22.58M | Operating profit |
| Net Income | FY 2025 | -$22.89M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$5.59 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$12.39M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $145K | Total debt: $1.36M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Research & Development | $11.11M | $31.03M | $4.40M | -- |
| Total Operating Expenses | $26.14M | $53.56M | $8.84M | -- |
| **Operating Income** | -$26.14M | -$53.56M | -$8.84M | -- |
| **EBITDA** | -$25.95M | -$53.40M | -$8.68M | -- |
| Interest Income | -- | -- | $2.73M | $4.95M |
| Interest Expense | -- | $184K | $1.21M | -- |
| Income Tax Expense | $4.8K | $1.8K | -- | -- |
| **Net Income** | -$26.28M | -$13.73M | -$60.48M | $4.41M |
| Basic EPS | -$451.40 | -$195.53 | -$6,815.64 | -- |
| **Diluted EPS** | -$451.40 | -$195.53 | -$6,815.64 | -- |
| Basic Shares Outstanding | 59.4K | 52.5K | 8.9K | -- |
| Diluted Shares Outstanding | 59.4K | 52.5K | 8.9K | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $2.96M | $3.28M | $3.13M | $2.11M | $3.11M | $2.70M | $3.20M | $2.84M |
| Total Operating Expenses | $6.90M | $5.66M | $5.40M | $4.61M | $5.73M | $5.44M | $10.36M | $9.36M |
| **Operating Income** | -$6.90M | -$5.66M | -$5.40M | -$4.61M | -$5.73M | -$5.44M | -$10.36M | -$9.36M |
| **EBITDA** | -$6.89M | -$5.63M | -$5.37M | -$4.55M | -$5.73M | -$5.35M | -$10.32M | -$9.32M |
| Interest Expense | -- | -- | -- | -- | -- | -- | $25K | $16K |
| **Net Income** | -$7.00M | -$5.76M | -$5.45M | -$4.68M | -$5.73M | -$5.50M | -$10.37M | -$9.44M |
| Basic EPS | -$1.76 | -$1.52 | -$89.94 | -- | -$1.50 | -$1.71 | -$181.56 | -- |
| **Diluted EPS** | -$1.76 | -$1.52 | -$89.94 | -- | -$1.50 | -$1.71 | -$181.56 | -- |
| Basic Shares Outstanding | 4.1M | 3.8M | 62.4K | -- | 3.9M | 3.3M | 57.8K | -- |
| Diluted Shares Outstanding | 4.1M | 3.8M | 62.4K | -- | 3.9M | 3.3M | 57.8K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $0 | $0 | $0 | $129K | $345K |
| **Cash & Short-Term Investments** | $0 | $0 | $0 | $129K | $345K |
| **Total Current Assets** | $1.54M | $2.36M | $1.72M | $274K | $791K |
| Property, Plant & Equipment, Net | $170K | $296K | $459K | -- | -- |
| Other Non-Current Assets | $1.07M | $576K | $271K | -- | -- |
| **Total Non-Current Assets** | $2.84M | $1.10M | $3.78M | $356.9M | $352.1M |
| **Total Assets** | $4.38M | $3.46M | $5.51M | $357.1M | $352.9M |
| Accounts Payable | $3.34M | $5.20M | $3.42M | -- | -- |
| Short-Term Debt | -- | -- | -- | $0 | -- |
| Other Current Liabilities | -- | -- | $230K | $140K | -- |
| **Total Current Liabilities** | $7.07M | $9.04M | $85.48M | $350K | $59K |
| **Total Non-Current Liabilities** | $5.55M | $1.09M | $14.45M | $14.71M | $15.12M |
| **Total Liabilities** | $12.62M | $10.14M | $99.93M | $15.06M | $15.18M |
| **Total Debt (incl. Leases)** | $1.45M | $235K | $488K | $0 | -- |
| Common Stock | $402 | $356 | $12K | -- | -- |
| Retained Earnings | -$139.7M | -$113.4M | -$99.66M | -$14.78M | -$14.23M |
| **Total Stockholders' Equity** | -$8.23M | -$6.67M | -$94.43M | -$33.95M | -$14.23M |
| Total Equity | -$8.23M | -$6.67M | -$94.43M | -$33.95M | -$14.23M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $145K | $1.08M | $692K | $0 | $1.04M | $685K | $1.97M | $0 |
| **Cash & Short-Term Investments** | $145K | $1.08M | $692K | $0 | $1.04M | $685K | $1.97M | $0 |
| **Total Current Assets** | $841K | $2.01M | $2.14M | $1.54M | $2.12M | $2.06M | $3.08M | $2.36M |
| Property, Plant & Equipment, Net | $96K | $110K | $140K | $170K | $164K | $164K | $256K | $296K |
| Other Non-Current Assets | $1.07M | $1.07M | $1.07M | $1.07M | $566K | $566K | $576K | $576K |
| **Total Non-Current Assets** | $2.67M | $2.72M | $2.78M | $2.84M | $2.37M | $2.21M | $995K | $1.10M |
| **Total Assets** | $3.51M | $4.73M | $4.92M | $4.38M | $4.49M | $4.27M | $4.07M | $3.46M |
| Accounts Payable | $2.96M | $2.83M | $3.80M | $3.34M | $3.31M | $4.24M | $4.66M | $5.20M |
| **Total Current Liabilities** | $6.37M | $6.15M | $7.27M | $7.07M | $6.74M | $8.08M | $8.72M | $9.04M |
| **Total Non-Current Liabilities** | $8.44M | $7.47M | $7.49M | $5.55M | $5.58M | $5.67M | $3.07M | $1.09M |
| **Total Liabilities** | $14.81M | $13.62M | $14.76M | $12.62M | $12.32M | $13.75M | $11.79M | $10.14M |
| **Total Debt (incl. Leases)** | $1.36M | $1.39M | $1.42M | $1.45M | $1.48M | $1.50M | $171K | $235K |
| Common Stock | $1.6K | $426 | $417 | $402 | $20K | $19K | $18K | $356 |
| Retained Earnings | -$158.7M | -$150.9M | -$145.1M | -$139.7M | -$135.0M | -$129.3M | -$123.8M | -$113.4M |
| **Total Stockholders' Equity** | -$11.29M | -$8.89M | -$9.84M | -$8.23M | -$7.82M | -$9.48M | -$7.72M | -$6.67M |
| Total Equity | -$11.29M | -$8.89M | -$9.84M | -$8.23M | -$7.82M | -$9.48M | -$7.72M | -$6.67M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$26.28M | -$13.73M | -$60.48M | $4.41M |
| Depreciation & Amortization | $191K | $162K | $163K | -- |
| Stock-Based Compensation | $16.22M | $40.76M | -- | -- |
| Change in Payables | -$1.96M | $1.69M | $1.11M | -- |
| **Operating Cash Flow** | -$12.33M | -$12.00M | -$8.17M | -$215K |
| Capital Expenditure | -$64K | -- | -$133K | -- |
| **Free Cash Flow** | -$12.39M | -- | -$8.30M | -- |
| **Investing Cash Flow** | -$64K | -- | -$133K | -- |
| Common Stock Issued | $4.86M | -- | -- | -- |
| Share Repurchases | -- | -- | -$343.0M | -- |
| **Financing Cash Flow** | $11.66M | $12.23M | $3.87M | -- |
| **Net Change in Cash** | -$731K | $231K | -$4.43M | -$215K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.00M | -$5.76M | -$5.45M | -$4.68M | -$5.73M | -$5.50M | -$10.37M | -$9.44M |
| Depreciation & Amortization | $14K | $30K | $30K | $58K | $518 | $91K | $41K | $41K |
| Stock-Based Compensation | $4.50M | $3.29M | $2.85M | $2.45M | $3.24M | $3.24M | $7.29M | $6.96M |
| Change in Payables | -- | -- | $458K | $28K | -$1.03M | -$424K | -$535K | -$638K |
| **Operating Cash Flow** | -$1.96M | -$3.01M | -$2.73M | -$2.18M | -$3.65M | -$3.19M | -$3.31M | -$3.05M |
| Common Stock Issued | -- | $428K | $874K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $1.02M | $3.40M | $2.87M | $1.76M | $4.00M | $1.90M | $4.00M | $2.00M |
| **Net Change in Cash** | -$937K | $390K | $140K | -$485K | $352K | -$1.29M | $692K | -$1.05M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -599.5% | -396.6% | -1098.5% | 1.2% |
| Current Ratio | 0.22x | 0.26x | 0.02x | 0.78x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.37x |
| **Net Income Growth (YoY)** | -- | -- | -1471.9% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -651.3% | -457.1% | -433.9% | -599.5% | -690.8% | -730.8% | -868.1% | -396.6% |
| Current Ratio | 0.13x | 0.33x | 0.29x | 0.22x | 0.31x | 0.25x | 0.35x | 0.26x |
| Quick Ratio | 0.02x | 0.18x | 0.10x | 0.00x | 0.15x | 0.08x | 0.23x | 0.00x |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -192.0% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -181.2% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
